Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Assets Average (2021 - 2025)

Historic Assets Average for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to $83.2 million.

  • Journey Medical's Assets Average rose 2872.02% to $83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.2 million, marking a year-over-year increase of 2872.02%. This contributed to the annual value of $78.5 million for FY2024, which is 1369.11% down from last year.
  • Journey Medical's Assets Average amounted to $83.2 million in Q3 2025, which was up 2872.02% from $83.1 million recorded in Q2 2025.
  • Journey Medical's 5-year Assets Average high stood at $117.2 million for Q2 2022, and its period low was $64.6 million during Q3 2024.
  • For the 5-year period, Journey Medical's Assets Average averaged around $86.4 million, with its median value being $82.9 million (2023).
  • In the last 5 years, Journey Medical's Assets Average plummeted by 3879.07% in 2023 and then surged by 2872.02% in 2025.
  • Quarter analysis of 5 years shows Journey Medical's Assets Average stood at $93.2 million in 2021, then grew by 14.47% to $106.7 million in 2022, then plummeted by 33.07% to $71.4 million in 2023, then grew by 1.06% to $72.1 million in 2024, then grew by 15.29% to $83.2 million in 2025.
  • Its Assets Average stands at $83.2 million for Q3 2025, versus $83.1 million for Q2 2025 and $82.6 million for Q1 2025.